Ajax-Loading

Novartis AG - Price Earnings Ratio

Novartis AG's Fiscal Year is From January To December.

The item "Price-Earnings-Ratio" stands at 16.73 as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Price Earnings Ratio" stands at 16.73. This represents a decrease of -25.80 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 32.51 percent compared to the value the year prior.
The 1 year change in percent is 32.51.
The 3 year change in percent is 189.39.

The Serie's long term average value is 19.73. It's latest available value, on 09/30/2025, is 15.22 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +189.39%.
The Serie's change in percent from it's maximum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is -74.61%.

Price Earnings Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price Earnings Ratio905,699,262,464.00
LogoJohnson & Johnson - Price Earnings Ratio486,508,953,600.00
LogoAbbVie Inc - Price Earnings Ratio399,570,305,024.00
LogoRoche Holding AG - Price Earnings Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price Earnings Ratio280,205,508,085.11